Thousands of papers due to be retracted after network of collaborating authors and peer reviewers uncovered by Retraction Watch.

Twelve French towns see bans on tap-water drinking over hormone-disrupting PFAS chemicals, as Australia introduces PFAS ban.

At first glance Close The Loop Group (ASX: CLG) looks superficially attractive, because it made an accounting profit and its business is good for the environment. Therefore, I’ve been asked about it ...

Xero’s $2.5B Melio buy aims for US growth, but at the cost of margins. Will it pay off, or repeat past acquisition mistakes? Key risks and analysis.

Yesterday afternoon, just before 5 pm, traffic enforcement company Acusensus (ASX: ACE) announced that a competitor in Australia, Redflex Pty Ltd, had commenced legal proceedings against both ...

The Camplify share price failed to respond to the FY 2023 Camplify results, despite very strong revenue growth and positive free cash flow.

I (GrowthGauge) first bought LaserBond (ASX: LBL) on 5 April 2019 at $0.425. The price soon doubled, then sank to $0.28 in the COVID crash. It climbed to almost $1.00 in 2021 and has drifted since.

Keypath Education (ASX: KED) has been a big disappointment for shareholders but Keypath share price already reflects this.

The Xero share price gained around 8% after its FY 2024 results, which showed unambiguous improvement in key operating metrics.

The Pro Medicus (ASX: PME) share price dropped 13% after it reported another set of strong results, albeit with slower half-on-half growth.